Results 171 to 180 of about 24,516 (282)

Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and Finland [PDF]

open access: diamond
Anders Rønneholt‐Frederiksen   +8 more
openalex   +1 more source

Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study. [PDF]

open access: yesAnn Hematol
Iori AP   +35 more
europepmc   +1 more source

Early access program for danicopan (ALXN2040) as add-on treatment to eculizumab or ravulizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH): Preliminary data from the Italian real-world survey. [PDF]

open access: bronze
Elisabetta Metafuni   +16 more
openalex   +1 more source

Complement C5 Inhibitor Ameliorates a Case of Dysferlinopathy. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Kang S   +9 more
europepmc   +1 more source

Eculizumab inhibits thrombotic microangiopathy and improves renal function in pediatric patients with atypical hemolytic uremic syndrome [PDF]

open access: yes, 2013
Al-Akash, Samhar I   +15 more
core  

Effect of early initation of Eculizumab in patients with aHUS on renal outcomes: a pooled analysis [PDF]

open access: yes, 2016
Ardissimo, Gianluigi   +5 more
core  

Home - About - Disclaimer - Privacy